You are here » Home » Companies » Company Overview » Bombay Oxygen Corporation Ltd

Bombay Oxygen Corporation Ltd.

BSE: 509470 Sector: Industrials
NSE: N.A. ISIN Code: N.A.
BSE LIVE 10:00 | 17 Oct Stock Is Not Traded.
NSE 05:30 | 01 Jan Stock Is Not Traded.
OPEN 5680.50
PREVIOUS CLOSE 5410.00
VOLUME 5
52-Week high 5689.00
52-Week low 5410.00
P/E 21.79
Mkt Cap.(Rs cr) 85
Buy Price 5680.50
Buy Qty 75.00
Sell Price 0.00
Sell Qty 0.00
OPEN 5680.50
CLOSE 5410.00
VOLUME 5
52-Week high 5689.00
52-Week low 5410.00
P/E 21.79
Mkt Cap.(Rs cr) 85
Buy Price 5680.50
Buy Qty 75.00
Sell Price 0.00
Sell Qty 0.00

Bombay Oxygen Corporation Ltd. (BOMBAYOXYGEN) - Company History

Bombay Oxygen Corporation (BOCL) was incorporated in 1960 to manufacture and market industrial gases. Shyam M Ruia is the chairman of the company. The company's manufacturing facilities are located in Nagpur, Tarapur, Pune, Nira, Khopoli, Kalwe and Mulund, all in Maharashtra. BOCL has a collaboration with General Electrodes and Equipments, Germany. The company has also entered into an agreement for procuring engineering services from Messer AGS Gmbh. In Mar.'95, it installed a capacity of 2.37 lac cu mtr for the manufacture of oxygen. The company manufactures various industrial gases such as oxygen, nitrogen, argon, compressed air, acetylene and medicinal oxygen. Its subsidiaries -- Savita Pharmaceuticals and Raptakos Brett & Company -- are engaged in the manufacture and distribution of pharmaceuticals. The company has designed and developed an indigenous cryogenic liquid oxygen pump for high-pressure gas-filling purposes. In 1996, the company has dis-invested in the shares of Raptakos Brett & Co. Therefore, Raptakos Brett & Co as also its subsidiaries, Raptakos Brett Test Laboratries and Sattva Pharmaceuticals ceased to be the company's subsidiaries. The company is also implementing new large tonnage Oxygen plant of 130 TPD at Kalwe, the same is expected to go on stream in 1999.